Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019;74(1):120–31.

Article  PubMed  Google Scholar 

Barcellos FC, Del Vecchio FB, Reges A, Mielke G, Santos IS, Umpierre D, Bohlke M, Hallal PC. Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial. J Hum Hypertens. 2018;32(6):397–407.

Article  PubMed  Google Scholar 

Dasgupta I, Zoccali C. Is the KDIGO systolic blood pressure target < 120 mm hg for chronic kidney Disease Appropriate in Routine Clinical Practice? Hypertension. 2022;79(1):4–11.

Article  CAS  PubMed  Google Scholar 

Kalaitzidis RG, Elisaf MS. Treatment of hypertension in chronic kidney disease. Curr Hypertens Rep. 2018;20(8):64.

Article  PubMed  Google Scholar 

Wilson S, Mone P, Jankauskas SS, Gambardella J, Santulli G. Chronic kidney disease: definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk. J Clin Hypertens (Greenwich). 2021;23(4):831–4.

Article  CAS  PubMed  Google Scholar 

Benetos A, Petrovic M, Strandberg T. Hypertension management in older and Frail older patients. Circ Res. 2019;124(7):1045–60.

Article  CAS  PubMed  Google Scholar 

Yuan Y, Chen S, Lin C, Huang X, Lin S, Huang F, Zhu P. Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study. Cardiovasc Diabetol. 2023;22(1):264.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richter D, Guasti L, Walker D, Lambrinou E, Lionis C, Abreu A, Savelieva I, Fumagalli S, Bo M, Rocca B, et al. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular diseases, WG e-Cardiology, WG thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol. 2022;29(1):216–27.

Article  PubMed  Google Scholar 

Mone P, Pansini A, Frullone S, de Donato A, Buonincontri V, De Blasiis P, Marro A, Morgante M, De Luca A, Santulli G. Physical decline and cognitive impairment in frail hypertensive elders during COVID-19. Eur J Intern Med. 2022;99:89–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pansini A, Lombardi A, Morgante M, Frullone S, Marro A, Rizzo M, Martinelli G, Boccalone E, De Luca A, Santulli G, et al. Hyperglycemia and physical impairment in Frail Hypertensive older adults. Front Endocrinol (Lausanne). 2022;13:831556.

Article  PubMed  Google Scholar 

Potok OA, Ix JH, Shlipak MG, Katz R, Hawfield AT, Rocco MV, Ambrosius WT, Cho ME, Pajewski NM, Rastogi A, et al. The difference between cystatin C- and creatinine-based estimated GFR and associations with Frailty and adverse outcomes: a cohort analysis of the systolic blood pressure intervention trial (SPRINT). Am J Kidney Dis. 2020;76(6):765–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mone P, Martinelli G, Lucariello A, Leo AL, Marro A, De Gennaro S, Marzocco S, Moriello D, Frullone S, Cobellis L, et al. Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study. Cardiovasc Diabetol. 2023;22(1):94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–156.

Article  CAS  Google Scholar 

American Diabetes Association Professional Practice C: 2. Diagnosis and classification of diabetes: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–42.

Article  Google Scholar 

Shi Y, Wen M. Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011–2018 population. Cardiovasc Diabetol. 2023;22(1):19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mone P, De Gennaro S, Frullone S, Marro A, Santulli G. Hyperglycemia drives the transition from pre-frailty to frailty: the monteforte study. Eur J Intern Med. 2023;111:135–7.

Article  PubMed  PubMed Central  Google Scholar 

Ostgren CJ, Otten J, Festin K, Angeras O, Bergstrom G, Cederlund K, Engstrom G, Eriksson MJ, Eriksson M, Fall T, et al. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study. Cardiovasc Diabetol. 2023;22(1):261.

Article  PubMed  PubMed Central  Google Scholar 

Potier L, Chequer R, Roussel R, Mohammedi K, Sismail S, Hartemann A, Amouyal C, Marre M, Le Guludec D, Hyafil F. Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bikbov B, Soler MJ, Pesic V, Capasso G, Unwin R, Endres M, Remuzzi G, Perico N, Gansevoort R, Mattace-Raso F, et al. Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence? Nephrol Dial Transpl. 2021;37(Suppl 2):ii55–62.

Article  Google Scholar 

Li M, Zhao Z, Qin G, Chen L, Lu J, Huo Y, Chen L, Zeng T, Xu M, Chen Y, et al. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes. Metabolism. 2021;124:154874.

Article  CAS  PubMed  Google Scholar 

Papademetriou V, Nylen ES, Doumas M, Probstfield J, Mann JFE, Gilbert RE, Gerstein HC. Chronic kidney disease, Basal Insulin Glargine, and Health outcomes in people with Dysglycemia: the ORIGIN study. Am J Med. 2017;130(12):1465. e1427-1465 e1439.

Article  Google Scholar 

Kinguchi S, Wakui H, Ito Y, Kondo Y, Azushima K, Osada U, Yamakawa T, Iwamoto T, Yutoh J, Misumi T, et al. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study). Cardiovasc Diabetol. 2019;18(1):110.

Article  PubMed  PubMed Central  Google Scholar 

Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD. National Kidney Foundation Kidney Disease Outcomes Quality I: practical Approach to detection and management of chronic kidney disease for the Primary Care Clinician. Am J Med. 2016;129(2):153–62. e157.

Article  PubMed  Google Scholar 

Horowitz B, Miskulin D, Zager P. Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis. 2015;22(2):88–95.

Article  PubMed  Google Scholar 

Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho CS, Cockram CS, Wong VC, Tong PC, et al. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry. Cardiovasc Diabetol. 2007;6:37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agarwal R. Albuminuria and masked uncontrolled hypertension in chronic kidney disease. Nephrol Dial Transpl. 2017;32(12):2058–65.

CAS  Google Scholar 

Kim SR, Lee YH, Lee SG, Kang ES, Cha BS, Lee BW. The renal tubular damage marker urinary N-acetyl-beta-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):16.

Article  PubMed  PubMed Central  Google Scholar 

Schechter M, Melzer Cohen C, Fishkin A, Rozenberg A, Yanuv I, Sehtman-Shachar DR, Chodick G, Clark A, Abrahamsen TJ, Lawson J, et al. Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence. Cardiovasc Diabetol. 2023;22(1):126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mielke N, Schneider A, Barghouth MH, Ebert N, van der Giet M, Huscher D, Kuhlmann MK, Schaeffner E. Association of kidney function and albuminuria with frailty worsening and death in very old adults. Age Ageing 2023, 52(5).

Miller LM, Rifkin D, Lee AK, Kurella Tamura M, Pajewski NM, Weiner DE, Al-Rousan T, Shlipak M, Ix JH. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction with Frailty Index and cognitive function in persons with CKD in SPRINT. Am J Kidney Dis. 2021;78(4):530–e540531.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Hao M, Li Y, Jiang X, Wang M, Chen J, Wang X, Sun X. Glomerular filtration rate by different measures and albuminuria are associated with risk of frailty: the Rugao Longitudinal Ageing Study. Aging Clin Exp Res. 2022;34(11):2703–11.

Article  PubMed  Google Scholar 

Liu M, He P, Zhou C, Zhang Z, Zhang Y, Li H, Liu C, Nie J, Liang M, Qin X. Association of urinary albumin:creatinine ratio with incident frailty in older populations. Clin Kidney J. 2022;15(6):1093–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Jiang Y, Li J, Yang M, Liu Y, Dong B, Li Y. Association between Frailty and Albuminuria among older Chinese inpatients. J Nutr Health Aging. 2021;25(2):197–200.

Article  CAS  PubMed  Google Scholar 

Mone P, Pansini A, Calabro F, De Gennaro S, Esposito M, Rinaldi P, Colin A, Minicucci F, Coppola A, Frullone S, et al. Global cognitive function correlates with P-wave dispersion in frail hypertensive older adults. J Clin Hypertens (Greenwich). 2022;24(5):638–43.

Article  CAS  PubMed  Google Scholar 

Sasso FC, Simeon V, Galiero R, Caturano A, De Nicola L, Chiodini P, Rinaldi L, Salvatore T, Lettieri M, Nevola R, et al. The number of risk